Article info
PDFCurrent controversy
What money can’t buy: an argument against paying people to get vaccinated
- Correspondence to Dr Nancy S Jecker, Department of Bioethics and Humanities, University of Washington School of Medicine, Seattle, WA 98195, USA; nsjecker{at}uw.edu
Citation
What money can’t buy: an argument against paying people to get vaccinated
Publication history
- Received January 11, 2021
- Revised March 8, 2021
- Accepted March 20, 2021
- First published April 2, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trial
- What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey
- Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
- COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities
- Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review
- How can early COVID-19 vaccine campaigns in the US-affiliated Pacific Islands inform future vaccine efforts: a cross-sectional analysis
- Covid-19 vaccination in pregnancy
- COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats
- Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study
- University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol